Analyst: Drusilla Whitmore, Senior Advisor
Date: August 2025
Investment Thesis
The Contemporary Art market continues to outperform global equities. While blue-chip names have entered a consolidation phase, we see outsized upside in mid-career, institutionally ascending artists. Our top picks—Hale, Nakamura, and Beltran—are positioned as “early-entry buys” with strong catalysts in the next 12–18 months.
Top Recommendations
- Elias Hale (U.S., b. 1984)
Rating: Overweight
Current Market Range: $60–90k (mid-size oils)
12-Month Price Target: $150k
Catalysts:
• Confirmed inclusion in the 2026 Newgale Biennial
• Critical coverage in The Art Trumpet (July 2025)
• Secondary-market liquidity tightening (only 3 works sold publicly in past 24 months)
Risk Factors:
• Overreliance on U.S. institutional support; limited European exposure
• Potential production slowdown due to health rumours
Whitmore View: Hale is trading at a 50–60% discount to peers with similar institutional exposure. Enter now, hold 24 months.
- Keiko Nakamura (Japan, b. 1979)
Rating: Strong Buy
Current Market Range: $18–30k (works on paper); $45–70k (large sculptures)
12-Month Price Target: $120k
Catalysts:
• Major solo announced at The Little Art Museum (Tokyo, Spring 2026)
• Gallery upgrade from regional representation to big name rumoured
• Aesthetic alignment with rising Asian megacollector demand
Risk Factors:
• Current works undervalued partly due to fragile materiality (silk/charcoal)
• Auction volatility in Asian evening sales could dampen confidence
Whitmore View: Nakamura is a classic breakout candidate—undervalued, under-collected, and due for a global re-rating.
- Mateo Beltran (Colombia, b. 1990)
Rating: Buy
Current Market Range: $12–22k (installations); $35–50k (paintings)
12-Month Price Target: $75k
Catalysts:
• Curatorial interest: shortlisted for 2026 Letterston Biennale
• “Green finance” angle—works made from reclaimed materials—aligns with ESG-oriented collections
• Recent press in Art on a Monday flagged him as a “climate vanguard artist”
Risk Factors:
• High production costs could slow supply
• Collecting base still narrow, reliant on sustainability-focused patrons
Whitmore View: Beltran offers the highest risk/reward profile in our coverage universe. Position size accordingly.
Sector Note
Liquidity remains concentrated in New York and London, but Tokyo and Seoul are emerging as secondary hubs. We recommend a barbell strategy: exposure to Hale (institutional blue-chip trajectory) balanced with Beltran (emerging, high-beta).
Bottom Line:
• Elias Hale: Steady compounder — “Art’s Microsoft.”
• Keiko Nakamura: Breakout catalyst play — “The Tesla of sculpture.”
• Mateo Beltran: Volatile disruptor — “The biotech stock of art.”